Clinical Trial Update: Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and tolerability of different concentrations of an ingenol derivative topical therapy for actinic keratosis, sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Ingenol Mebutate (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 1 | Status: COMPLETED